Business Wire

VADSA Selects MDS Global’s VNOnDemand Solution to Launch New MVNO

Share

MDS Global Ltd, a leading BSS-as-a-Service provider today announced that, Mexican-based MVNE, Valor Agregado Digital, S.A. de C.V. (“VADSA”) has chosen MDS Global’s MVNO solution, VNOnDemand to facilitate the launch of an innovative MVNO in Mexico.

VADSA has recently signed a Mobile Wholesale Agreement with Altán Redes, Mexico’s first 700Mhz 4G-LTE Mobile Operator and will later this year launch an MVNO called Exis Telecom which will offer a real-time, wholly digital customer experience with content-based, application-based, and traditional voice and data packages. For a fully digital MVNO, VADSA want to overcome the challenges of targeting the consumer and business market segments using traditional pre-paid solutions or separate B2C/B2B stacks. Most of the customer engagement will be driven via a self-serve portal.

The full MVNO project, which includes web portals, mobile apps, BSS, online charging and core network components such as HSS, DPI and Voicemail, will be primed by MDS Global. It will initially support the Exis MVNO but is being implemented as a full MVNE platform to subsequently support other MVNOs in the Mexican market.

The solution will benefit the entire VADSA organisation, including marketing and service design, sales and on-boarding, customer and revenue management, operations, network management, and, most importantly, the end customers.

Business benefits of MDS Global’s VNOnDemand solution include:

  • The rapid launch of an MVNO into a competitive and fast-moving market.
  • A complete real-time and wholly digital customer experience.
  • Content-based and application-based service offerings as well as traditional voice/data packages.
  • Ability to target consumer and business segments using a single solution.
  • An end-to-end solution supporting an organisation from the BSS back-end, to business analytics, and customer portal at the front.

Natalia Saenz, President of VADSA, “We are about to embark on an exciting project which will offer new and differentiated services to the people of Mexico. MDS Global’s solution will provide us with the capabilities to successfully launch and operate a new MVNO on time and to budget. Jose Luis Sanchez, our CEO is taking VADSA into a next generation of telcos that need to focus on the customer and this customer-centric solution ensures we are future-proofed for today and tomorrow’s projects.”

MDS Global’s CEO, Gary Bunney, says, “VADSA’s choice of MDS Global as their MVNO monetisation platform quickly follows that of other service providers looking for a more comprehensive, complete solution. It solidifies our unique and respected approach to the VNO journey. Our pre-integrated combination of analytics, industry insight, experience and monetisation, offered as a service, speeds time to market for new entrants and those looking to improve their ability to service business and customer expectation and demand.”

He continues, “We are extremely proud that VADSA has chosen the MDS Global solution and we look forward to partnering with them on their journey, not only with Exis, but with the other MVNO’s they plan to launch in region going forward.”

About MDS Global

MDS Global, a leading BSS-as-a-Service provider of VNO, B2B and IoT solutions look after all aspects of monetisation, assurance and customer steering for complex products and services. We offer a digital operating model in a DevOps context, which enhances stakeholder experiences and provides unprecedented business agility.

Headquartered in the UK, MDS Global’s customers include BT Enterprise (UK), eir (Ireland), iD Mobile from Dixons Carphone (UK), TalkTalk (UK), Telefónica (UK), Vodafone (Germany, Greece and NL), Orange (Belgium), KPN (Netherlands) and Telia (Denmark).

www.mdsglobal.com.

Contact information

Martine Naughton
MDS Global
martine.naughton@mdsglobal.com
+44 (0) 7909 475815

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Velodyne Files Patent Infringement Complaint with ITC Against Hesai and RoboSense16.8.2019 12:00:00 CESTPress release

Velodyne Lidar, Inc. filed a patent infringement complaint with the U.S. International Trade Commission (ITC) against Hesai Photonics Technology Co., Ltd. and Suteng Innovation Technology Co., Ltd. (a.k.a. RoboSense) for violations of section 337 of the Tariff Act of 1930 which makes unfair methods of competition and importation of certain products into the United States unlawful. Earlier this week, Velodyne also filed patent infringement complaints against Hesai and RoboSense in the U.S. District Court for the Northern District of California. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190816005041/en/ Velodyne Lidar’s Alpha Puck™, Ultra Puck™ and Puck™ surround view sensors (left to right). (Photo: Business Wire) Velodyne is asking the ITC to investigate these lidar manufacturers for unlawfully importing and selling lidar sensors that infringe Velodyne’s patented lidar technology (U.S. Patent 7,969,558). Velodyne reques

Merz Announces Key Governance Changes16.8.2019 09:26:00 CESTPress release

Merz, a global leader in medical aesthetics and specialty neurology, announced today that Philip Burchard will be appointed Chairman of the company’s Shareholders Council. He will assume this role in addition to his current position as Chief Executive Officer of the Merz Healthcare Group. In his new position, Philip Burchard will succeed Andreas Krebs, who has decided to step down from his current roles as Chairman of the Shareholders Council and Supervisory Board of Merz in order to dedicate more time to his personal entrepreneurial and philanthropic activities. In addition, Dr. Christian Holzherr will be the new Chairman of the Merz Supervisory Board. All changes will be effective as of October 31, 2019. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190816005106/en/ Philip Burchard, CEO of Merz (Photo: Business Wire) Philip Burchard joined Merz as CEO in July 2012. Under his leadership, Merz has focused its strategy on ae

FINEOS lists on the Australian Securities Exchange16.8.2019 07:22:00 CESTPress release

FINEOS Corporation Holdings plc (ASX:FCL), a leading provider of group and individual core systems for life, accident and health insurance, today announced the commencement of trading on the Australian Securities Exchange (ASX) via an initial public offering (IPO). The total number of securities (CHESS Depository Interests or “CDIs”) on offer was 84.4 million at a price of A$2.50 per CDI. Total gross proceeds from the offer amounted to A$211 million. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190816005058/en/ FINEOS lists on the Australian Securities Exchange (Photo: Business Wire) FINEOS intends to use the net proceeds from the IPO to invest further in R&D to grow the FINEOS product footprint and develop new business lines, to invest in additional sales, marketing and client account management capabilities and to pay down existing debt and shareholders selling down. Key areas of growth strategy for FINEOS include: • Inc

European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis15.8.2019 20:01:00 CESTPress release

Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Marketing Authorization Application (MAA) for filgotinib, an investigational, oral, selective JAK1 inhibitor, for the treatment of adults with rheumatoid arthritis (RA) has been validated and is now under evaluation by the European Medicines Agency (EMA). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190815005605/en/ “We are excited about the validation of this application which is an important milestone in our ongoing work to improve the lives of people living with rheumatoid arthritis and other inflammatory conditions,” said John Sundy, MD, PhD, Senior Vice President, Inflammation and Respiratory Diseases, Gilead Sciences. The MAA for filgotinib is supported by 24-week data from the Phase 3 FINCH clinical trials in which once-daily treatment with filgotinib achieved improvements in clinical signs and symptoms, achievem

Celsius Network Partners With Bitcoin.com15.8.2019 14:55:00 CESTPress release

Celsius Network, the industry-leading cryptocurrency platform, has announced a new partnership with Bitcoin.com, the leading resource for Bitcoin trading, news, and updates. Users of Celsius services are now able to purchase BCH, BTC, ETH, and other mutually supported cryptocurrencies through the Celsius app using Bitcoin.com’s advanced crypto trading platform providing low fees, enhanced accessibility to cryptocurrency, and valuable crypto services. With the shared mission of making financial services fair, rewarding, and transparent, Celsius and Bitcoin.com are well-known in the space for offering inclusive services designed to support the needs and interests of their robust communities. Celsius members can earn interest income of up to 10.53% APR on crypto assets and use their coins as collateral to get dollar loans at rates as low as 4.95% without fees or penalties, no minimums or caps, and no lockups. Bitcoin.com makes it easy to buy dozens of crypto assets instantly and without f

Anesthesia Patient Safety Foundation and Patient Safety Movement Foundation Offer $100,000 Patient Safety Curriculum Award15.8.2019 12:58:00 CESTPress release

The Anesthesia Patient Safety Foundation (APSF), in partnership with the Patient Safety Movement Foundation (PSMF), is now accepting proposals for the Patient Safety Curriculum Award. The $100,000 award will go to an anesthesia education investigator with the intent to modify the PSMF Patient Safety Curriculum to address perioperative patient safety. The awardee will also test the educational efficiency and effectiveness of implementing the curriculum in anesthesia training programs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190815005377/en/ Anesthesia Patient Safety Foundation and Patient Safety Movement Foundation Offer $100,000 Patient Safety Curriculum Award (Graphic: Business Wire) “This important work will add to the considerable value provided by PSMF’s Patient Safety Curriculum,” said Mark Warner, APSF President. “To ensure the safety of patients and achieve our collective goal of zero preventable deaths in hosp